Coadministration of black seeds and turmeric shows enhanced efficacy in preventing metabolic syndrome in fructose-fed rats

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 2, 2015, Pages 176-183

  Amin, Faridah ^a   Gilani, Anwarul Hassan ^a,c   Mehmood, Malik Hassan ^a   Siddiqui, Bina S ^b   Khatoon, Nasima ^b  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

^c MEKELLE UNIVERSITY   (Ethiopia)

Author keywords

fructose fed rats; metabolic syndrome; turmeric and black seeds

Indexed keywords

ATORVASTATIN; CAPTOPRIL; CURCUMIN; FRUCTOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NIGELLA SATIVA EXTRACT; THYMOQUINONE; TURMERIC; BENZOQUINONE DERIVATIVE; GLUCOSE BLOOD LEVEL; PLANT MEDICINAL PRODUCT; SWEETENING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLACK CUMIN; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; RAT; ANALYSIS; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMISTRY; CURCUMA; DRUG COMBINATION; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; PHYTOTHERAPY; PLANT SEED; PROCEDURES; TREATMENT OUTCOME;

ANIMALS; BENZOQUINONES; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, LDL; CURCUMA; CURCUMIN; DRUG THERAPY, COMBINATION; FRUCTOSE; METABOLIC SYNDROME X; PHYTOTHERAPY; PLANT PREPARATIONS; RATS; SEEDS; SWEETENING AGENTS; TREATMENT OUTCOME;

EID: 84925483452     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000179     Document Type: Article

References (49)

1. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683.
2. Grundy SM, Hansen B, Smith SC Jr, et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004;109:551.
3. Aroda VR, Ratner R. Approach to the patient with prediabetes. J Clin Endocrinol Metab. 2008;93:3259-3265.
4. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24:13-18.
5. Gilani AH, Jabeen Q, Khan MAU. A review of medicinal uses and pharmacological activities of Nigella sativa. Pak J Biol Sci. 2004;7:441-451.
6. Ali B, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17:299-305.
7. Kanter M, Coskun O, Korkmaz A, et al. Effects of Nigella sativa on oxidative stress and cell damage in streptozotocin induced diabetic rats. Anat Rec A Discov Mol Cell Evol Biol. 2004;279:685-691.
8. Benhaddou Andaloussi A, Martineau L, Vallerand D, et al. Multiple molecular targets underlie the antidiabetic effect of Nigella sativa seed extract in skeletal muscle, adipocyte and liver cells. Diabetes Obes Metab. 2010;12:148-157.
9. Gilani A, Aziz N, Khurram I, et al. Bronchodilator, spasmolytic and calcium antagonist activities of Nigella sativa seeds (Kalonji): a traditional herbal product with multiple medicinal uses. JPMA. 2001;51:115-120.
10. Chattopadhyay I, Biswas K, Bandyopadhyay U, et al. Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci. 2004;87:44-53.
11. Singletary K. Turmeric: an overview of potential health benefits. Nutr Today. 2010;45:216.
12. Alappat L, Awad AB. Curcumin and obesity: evidence and mechanisms. Nutr Rev. 2010;68:729-738.
13. Ahmed T, Gilani AH. Therapeutic potential of turmeric in Alzheimer's disease: curcumin or curcuminoids? Phytother Res. 2014;28:517-525.
14. Prasad S, Aggarwal BB. Turmeric, the Golden Spice. In: Benzie IF, Wachtel-Galor S, eds. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton, FL: CRC Press, 2011.
15. Gilani AH, Shah A, Ghayur MN, et al. Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci. 2005; 76:3089-3105.
16. Gilani AH, Atta-ur-Rahman. Trends in Ethnopharmacology. J Ethnopharmacol. 2005;100:43-49.
17. Weng J-K, Philippe RN, Noel JP. The rise of chemodiversity in plants. Science. 2012;336:1667-1670.
18. Le PM, Benhaddou-Andaloussi A, Elimadi A, et al. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J Ethnopharmacol. 2004;94:251-259.
19. Um MY, Hwang KH, Ahn J, et al. Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase. Basic Clin Pharmacol Toxicol. 2013;113:152-157.
20. Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16:97-110.
21. De Moura RF, Ribeiro C, de Oliveira JA, et al. Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols. Br J Nutr. 2009;101:1178-1184.
22. Di Verniero CA, Silberman EA, Mayer MA, et al. In vitro vivo pharmacodynamic properties metoprolol fructose-fed hypertensive rats. J Cardiovasc Pharmacol. 2008;51:532-541.
23. Amin F, Gilani AH. Fiber-free white flour with fructose offers a better model of metabolic syndrome. Lipids Health Dis. 2013;12:44.
24. Van Vliet BN, Chafe LL, Antic V, et al. Direct and indirect methods used to study arterial blood pressure. J Pharmacol Toxicol. 2000;44:361-373.
25. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288:373-376.
26. Jang E-M, Choi M-S, Jung UJ, et al. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism. 2008;57:1576-1583.
27. Kuroda M, Mimaki Y, Nishiyama T, et al. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull. 2005;28:937-939.
28. Weisberg SP, Leibel R, Tortoriello DV. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology. 2008;149:3549.
29. Rchid H, Chevassus H, Nmila R, et al. Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets. Fundam Clin Pharmacol. 2004;18:525-529.
30. Majithiya JB, Balaraman R. Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin. J Cardiovasc Pharmacol. 2005;46:697-705.
31. Shehzad A, Ha T, Subhan F, et al. New mechanisms and the antiinflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr. 2011;50:151-161.
32. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58:621-681.
33. Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharmaceutics. 2007;4:807-818.
34. Barbosa C, Albuquerque E, Faria E, et al. Opposite lipemic response of Wistar rats and C57BL/6 mice to dietary glucose or fructose supplementation. Braz J Med Biol Res. 2007;40:323-331.
35. Lee Y-C, Ko Y-H, Hsu Y-P, et al. Plasma leptin response to oral glucose tolerance and fasting/re-feeding tests in rats with fructose-induced metabolic derangements. Life Sci. 2006;78:1155-1162.
36. Tagzirt M, Corseaux D, Pasquesoone L, et al. Alterations in neutrophil production and function at an early stage in the high-fructose rat model of metabolic syndrome. Am J Hypertens. 2014;27:1096-1104.
37. Tzeng TF, Liou SS, Liu IM. Myricetin ameliorates defective postreceptor insulin signaling via beta-Endorphin signaling in the skeletal muscles of Fructose-Fed rats. Evid Based Complement Alternat Med. 2011;2011:150752.
38. Sánchez-Lozada LG, Tapia E, Jiménez A, et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol. 2007;292: F423.
39. Padiya R, Khatua TN, Bagul PK, et al. Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats. Nutr Metab (Lond). 2011;8:53.
40. Masoudi FA, Inzucchi SE, Wang Y, et al. Thiazolidinediones, Metformin, and outcomes in older patients with Diabetes and Heart Failure an observational study. Circulation. 2005;111:583-590.
41. Ortlepp JR, Breuer J, Eitner F, et al. Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia. Eur J Pharmacol. 2002;436:145-150.
42. Kunitomo M, Yamaguchi Y, Kagota S, et al. Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome. J Pharmacol Sci. 2008;107:128-137.
43. Dewar AM, Clark RA, Singer AJ, et al. Curcumin mediates both dilation and constriction of peripheral arterioles via adrenergic receptors. J Invest Dermatol. 2011;131:1754-1760.
44. Xi L, Xiao C, Bandsma RH, et al. C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases. Hepatology. 2011;53:127-135.
45. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983-1992.
46. Katakam PV, Ujhelyi MR, Hoenig ME, et al. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol. 1998;275:788-792.
47. Verma S, Bhanot S, Yao L, et al. Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens. 1996;9: 370-376.
48. Rodrigo E, Maeso R, Munoz-Garcia R, et al. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril. J Hypertens. 1997;15:613-618.
49. Woods V, Coleman-Shepherd G, Runnels J, et al. The effects of captopril treatment and exercise training on blood pressure and endothelium function in the spontaneously hypertensive rat. FASEB J. 2012; 26:abstr 872.37.